Netrin-1 simultaneously suppresses corneal inflammation and neovascularization

Area of Science:

• Ophthalmology
• Regenerative Medicine
• Molecular Biology

Background:

• Corneal alkali burns cause significant inflammation and neovascularization, leading to vision impairment.
• Netrin-1, a guidance protein, plays roles in tissue repair and development.
• Understanding netrin-1's role in corneal injury is crucial for developing new therapies.

Purpose of the Study:

• To investigate the therapeutic potential of netrin-1 in alkali burn-induced corneal inflammation and neovascularization.
• To elucidate the molecular mechanisms underlying netrin-1's effects on corneal healing.

Main Methods:

• Gene and protein expression analysis (RT-PCR, Western blot, immunostaining) of netrin-1 and its receptors in rat corneas.
• Topical administration of exogenous netrin-1 to treat alkali-burned rat corneas.
• Assessment of corneal inflammation, neovascularization, and cell apoptosis using microscopy and specific assays.
• Evaluation of growth factor expression (EGF, VEGF, PEDF) via Western blot.

Main Results:

• Netrin-1 and its receptor UNC5B expression decreased in alkali-burned corneas.
• Topical netrin-1 application significantly reduced corneal inflammation and suppressed neovascularization.
• Netrin-1 reversed existing neovascularization and accelerated epithelial wound healing.
• Netrin-1 upregulated epidermal growth factor (EGF) and modulated VEGF/PEDF balance, while inhibiting inflammatory cell infiltration and apoptosis.

Conclusions:

• Netrin-1 demonstrates potent anti-inflammatory and anti-neovascularization effects in alkali-burned corneas.
• Netrin-1 can inhibit and reverse corneal neovascularization, offering a promising therapeutic strategy.
• The findings highlight netrin-1's multifaceted role in promoting corneal tissue repair.